| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000019924 |
| Receipt No. | R000023001 |
| Scientific Title | Association of macular pigment optical density and eye condition |
| Date of disclosure of the study information | 2015/11/25 |
| Last modified on | 2020/04/25 (Ver. 5) |
| Basic information | ||
| Public title | Association of macular pigment optical density and eye condition | |
| Acronym | MPOD and eye codition | |
| Scientific Title | Association of macular pigment optical density and eye condition | |
| Scientific Title:Acronym | MPOD and eye codition | |
| Region |
|
|
| Condition | ||
| Condition | patients with eye diseases and healthy cases | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the association of MPOD, visual function, eye and systemic condition |
| Basic objectives2 | Others |
| Basic objectives -Others | cross-sectional |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | MPOD, visual function, eye exam and blood exam |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with eye diseases and healthy cases | |||
| Key exclusion criteria | Those who cannot undergo the examinations | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University | ||||||
| Division name | Department of Ophthalmology, School of Medicine | ||||||
| Zip code | 1608582 | ||||||
| Address | 35 Shinanomachi, Shinjukuku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| ozawa@a5.keio.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University | ||||||
| Division name | Department of Ophthalmology, School of Medicine | ||||||
| Zip code | 1608582 | ||||||
| Address | 35 Shinanomachi, Shinjukuku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| Homepage URL | |||||||
| ozawa@a5.keio.jp | |||||||
| Sponsor | |
| Institute | Keio University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Keio University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Keio University School of Medicine |
| Address | 35 Shinanomachi Shinjukuku Tokyo |
| Tel | 0333531211 |
| ozawa@a5.keio.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Case control study. Patients who visited Keio University Hospital after the registration starting date or healthy volunteears, who agreed to join the study are included. They receive MPOD, visual function, eye and blood exams. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023001 |